These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking. Souri M; Osaki T; Ichinose A J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477 [TBL] [Abstract][Full Text] [Related]
8. Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure. Groeneveld DJ; Poole LG; Bouck EG; Schulte A; Wei Z; Williams KJ; Watson VE; Lisman T; Wolberg AS; Luyendyk JP J Thromb Haemost; 2023 Sep; 21(9):2430-2440. PubMed ID: 37054919 [TBL] [Abstract][Full Text] [Related]
9. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement. Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939 [TBL] [Abstract][Full Text] [Related]
10. The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. Smith KA; Pease RJ; Avery CA; Brown JM; Adamson PJ; Cooke EJ; Neergaard-Petersen S; Cordell PA; Ariëns RA; Fishwick CW; Philippou H; Grant PJ Blood; 2013 Mar; 121(11):2117-26. PubMed ID: 23303819 [TBL] [Abstract][Full Text] [Related]
11. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis. Duval C; Ali M; Chaudhry WW; Ridger VC; Ariëns RA; Philippou H Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):308-16. PubMed ID: 26743168 [TBL] [Abstract][Full Text] [Related]
15. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Ganey PE; Luyendyk JP; Newport SW; Eagle TM; Maddox JF; Mackman N; Roth RA Hepatology; 2007 Oct; 46(4):1177-86. PubMed ID: 17654741 [TBL] [Abstract][Full Text] [Related]
16. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914 [TBL] [Abstract][Full Text] [Related]
17. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
18. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture. Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225 [TBL] [Abstract][Full Text] [Related]
19. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Achyuthan KE; Dobson JV; Greenberg CS Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839 [TBL] [Abstract][Full Text] [Related]
20. Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodeling. Tsujimoto I; Moriya K; Sakai K; Dickneite G; Sakai T Am J Pathol; 2011 Dec; 179(6):3011-9. PubMed ID: 22019897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]